Eli Lilly Canada Inc. v. Teva Canada Ltd., 2023 FC 9 (Tadalafil*)
Justice St-Louis - 2023-01-06
Read full decision. Automatically generated summary:
This Motion is brought by Teva seeking directions as to costs associated with the liability phase of this proceeding as it relates to the 684 Patent. The requested awards also seek Teva’s costs in defending the Plaintiffs’ infringement claims in respect of the 540 Patent and the 948 Patent incurred prior to the Plaintiffs dropping their claims of infringement of these Patents against Teva. ... For the reasons that follow, I will award Teva total costs of $371,260.50 inclusive of all fees, disbursements, and tax.
Decision relates to:
- T-1631-16 - ELI LILLY CANADA INC. ET AL. v. TEVA CANADA LIMITED